Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal tamoxifen for sexual function in postmenopausal women with breast cancer on aromatase inhibitors
2024-517315-69-00Phase 3Completed
- Sponsor
- Uppsala University
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in vaginal atrophy comparing Vaginal tamoxifen with Placebo (2 arms). Primary endpoint: Change in modified Endocrine Subscale-FACT-B symptom score. Started Aug 2024; status: completed.
02
Drugs
tamoxifen
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on 2024-517315-69-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517315-69-00.